DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification.

Item

http://www.wikidata.org/entity/Q43729633

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

DEK-CAN molecular monitoring o ...... id therapeutic stratification.

@en

DEK-CAN molecular monitoring o ...... id therapeutic stratification.

@nl

type

Item

label

DEK-CAN molecular monitoring o ...... id therapeutic stratification.

@en

DEK-CAN molecular monitoring o ...... id therapeutic stratification.

@nl

prefLabel

DEK-CAN molecular monitoring o ...... id therapeutic stratification.

@en

DEK-CAN molecular monitoring o ...... id therapeutic stratification.

@nl

P1476

DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratification

@en

P2093

Asnafi V

http://www.w3.org/2001/XMLSchema#string

Berger C

http://www.w3.org/2001/XMLSchema#string

Buzyn A

http://www.w3.org/2001/XMLSchema#string

Garçon L

http://www.w3.org/2001/XMLSchema#string

Leblanc T

http://www.w3.org/2001/XMLSchema#string

Libura M

http://www.w3.org/2001/XMLSchema#string

Macintyre E

http://www.w3.org/2001/XMLSchema#string

Schmitt C

http://www.w3.org/2001/XMLSchema#string

Valensi F

http://www.w3.org/2001/XMLSchema#string

P2860

The human CAN protein, a putative oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex protein that faces the cytoplasm

Overexpression of the nucleoporin CAN/NUP214 induces growth arrest, nucleocytoplasmic transport defects, and apoptosis

The (6;9) chromosome translocation, associated with a specific subtype of acute nonlymphocytic leukemia, leads to aberrant transcription of a target gene on 9q34

The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA

Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461)

The ubiquitous chromatin protein DEK alters the structure of DNA by introducing positive supercoils

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

6;9 translocation in myelodysplastic syndrome.

Detection of minimal residual disease in acute myeloid leukaemia: methodologies, clinical and biological significance.

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis.

P2888

sj.leu.2403835

P304

1338-1344

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.LEU.2403835

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Eric Delabesse

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7770977

http://www.w3.org/2001/XMLSchema#string

P6179

1017630347

http://www.w3.org/2001/XMLSchema#string

P698

15973457

http://www.w3.org/2001/XMLSchema#string